Clinical Trial Update: Oral Lenalidomide and Intravesical BCG for Therapy of Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial updating the use of oral lenalidomide in combination with intravesical BCG for bladder cancer has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• BCG (intravesical)
• Lenalidomide (lenalidomide)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-05-12